Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Feb;4(1):4-14.
doi: 10.1177/2045125313499065.

Comparison of the effects of Sertindole and Olanzapine on Cognition (SEROLA): a double-blind randomized 12-week study of patients diagnosed with schizophrenia

René Ernst Nielsen  1 , Florence Odur  2 , Torben Ostergaard  3 , Povl Munk-Jørgensen  4 , Jimmi Nielsen  5
Affiliations

Comparison of the effects of Sertindole and Olanzapine on Cognition (SEROLA): a double-blind randomized 12-week study of patients diagnosed with schizophrenia

René Ernst Nielsen et al. Ther Adv Psychopharmacol. 2014 Feb.

Abstract

Objective: To assess the cognitive effects of sertindole and olanzapine in patients diagnosed with schizophrenia. Cognition was the primary outcome of the study.

Method: This was a 12-week double-blinded randomized clinical controlled trial. Participants were randomized to either 16-24 mg of sertindole or 10-20 mg of olanzapine.

Results: The study had a low recruitment rate (N = 9) and was terminated before the expected number of patients was reached. No significant differences between groups were found at study end on any of the 32 cognitive subtests. A simple sign test did not show any of the comparator drugs trending towards being superior on the majority of tests. Mean change on Positive and Negative Syndrome Scale (PANSS) total and PANSS subscales from baseline to end of study were not significantly different between treatment groups. Similar results on cognition and PANSS was seen on completers and last observation carried forward analysis.

Conclusion: In this study we did not find any significant differences between sertindole or olanzapine on PANSS subscales or neurocognitive tests in a population consisting of patients diagnosed with schizophrenia.

Keywords: cognition; olanzapine; randomized controlled trial; schizophrenia; sertindole.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest statement: The Unit for Psychiatric Research provided support with researchers’ salaries and overheads. R. Nielsen has received research grants from H. Lundbeck for clinical trials, received speaking fees from Bristol-Myers Squibb, Astra Zeneca, Janssen & Cilag, Lundbeck, Servier, Otsuka Pharmaceuticals and has acted as advisor to Astra Zeneca and Otsuka Pharmaceuticals. J. Nielsen has received research support from Pfizer and Lundbeck and has received speakers’ honoraria from AstraZeneca, Bristol-Myers Squibb, HemoCue and Lundbeck.

Figures

Figure 1.
Figure 1.
Patient flow throughout the study.
See this image and copyright information in PMC

References

    1. Addington D., Addington J., Maticka-Tyndale E. (1994) Specificity of the Calgary Depression Scale for Schizophrenics. Schizophr Res 11: 239–244 - PubMed
    1. Addington D., Addington J., Maticka-Tyndale E., Joyce J. (1992) Reliability and validity of a depression rating scale for schizophrenics. Schizophr Res 6: 201–208 - PubMed
    1. Buchanan R., Davis M., Goff D., Green M., Keefe R., Leon A., et al. (2005) A summary of the FDA-NIMH-MATRICS workshop on clinical trial design for neurocognitive drugs for schizophrenia. Schizophr Bull 31: 5–19 - PubMed
    1. Cannon T., Zorrilla L., Shtasel D., Gur R., Gur R., Marco E., et al. (1994) Neuropsychological functioning in siblings discordant for schizophrenia and healthy volunteers. Arch Gen Psychiatry 51: 651–661 - PubMed
    1. Caspi A., Reichenberg A., Weiser M., Rabinowitz J., Kaplan Z., Knobler H., et al. (2003) Cognitive performance in schizophrenia patients assessed before and following the first psychotic episode. Schizophr Res 65: 87–94 - PubMed

LinkOut - more resources